Cargando…

ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice

Diabetes leads to an elevated risk of stroke and worse functional outcome compared to the general population. We investigate whether L-4F, an economical ApoA-I mimetic peptide, reduces neurovascular and white-matter damage in db/db type-2 diabetic (T2DM) stroke mice. L-4F (16 mg/kg, subcutaneously a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaohui, Li, Rongwen, Zacharek, Alex, Landschoot-Ward, Julie, Chopp, Michael, Chen, Jieli, Cui, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823666/ https://www.ncbi.nlm.nih.gov/pubmed/31708728 http://dx.doi.org/10.3389/fnins.2019.01127

Ejemplares similares

ABCA1/ApoE/HDL Signaling Pathway Facilitates Myelination and Oligodendrogenesis after Stroke
por: Li, Li, et al.
Publicado: (2020)

Administration of Downstream ApoE Attenuates the Adverse Effect of Brain ABCA1 Deficiency on Stroke
por: Wang, Xiaohui, et al.
Publicado: (2018)

Angiopoietin-1 Mimetic Peptide Promotes Neuroprotection after Stroke in Type 1 Diabetic Rats
por: Venkat, Poornima, et al.
Publicado: (2018)

Treatment with an Angiopoietin‐1 mimetic peptide promotes neurological recovery after stroke in diabetic rats
por: Venkat, Poornima, et al.
Publicado: (2020)

Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice
por: Zhou, Min, et al.
Publicado: (2022)

Deficiency of tPA Exacerbates White Matter Damage, Neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice
por: Yu, Peng, et al.
Publicado: (2019)

Treatment With an Angiopoietin-1 Mimetic Peptide Improves Cognitive Outcome in Rats With Vascular Dementia
por: Culmone, Lauren, et al.
Publicado: (2022)

Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia
por: Gao, Huanjia, et al.
Publicado: (2023)

HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia
por: Venkat, Poornima, et al.
Publicado: (2020)

Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia
por: An, Lulu, et al.
Publicado: (2021)

Brain-Derived Microparticles (BDMPs) Contribute to Neuroinflammation and Lactadherin Reduces BDMP Induced Neuroinflammation and Improves Outcome After Stroke
por: Chen, Zhili, et al.
Publicado: (2019)

Endothelial Nitric Oxide Synthase Regulates White Matter Changes via the BDNF/TrkB Pathway after Stroke in Mice
por: Cui, Xu, et al.
Publicado: (2013)

Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke
por: Chen, Jieli, et al.
Publicado: (2009)

Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats
por: Ye, Xinchun, et al.
Publicado: (2013)

An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration
por: Chen, Xun, et al.
Publicado: (2009)

ApoA-1 in Diabetes: Damaged Goods
por: Ory, Daniel S., et al.
Publicado: (2010)

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
por: Cedó, Lídia, et al.
Publicado: (2016)

ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV
por: Daskou, Maria, et al.
Publicado: (2022)

Neurorestorative Therapy for Stroke
por: Chen, Jieli, et al.
Publicado: (2014)

Intracerebral Hemorrhage Induces Cardiac Dysfunction in Mice Without Primary Cardiac Disease
por: Li, Wei, et al.
Publicado: (2018)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Cardiac Dysfunction in a Mouse Vascular Dementia Model of Bilateral Common Carotid Artery Stenosis
por: An, Lulu, et al.
Publicado: (2021)

An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
por: Song, Xuelei, et al.
Publicado: (2009)

FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice
por: Uehara, Yoshinari, et al.
Publicado: (2013)

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
por: Ma, Cheng, et al.
Publicado: (2015)

D-4F, an ApoA-I mimetic peptide ameliorating TRPA1-mediated nocifensive behaviour in a model of neurogenic inflammation
por: Oehler, Beatrice, et al.
Publicado: (2020)

Blood–Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke
por: Venkat, Poornima, et al.
Publicado: (2017)

Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity
por: Yoo, Jeong-Ah, et al.
Publicado: (2015)

SIDT2 Associates with Apolipoprotein A1 (ApoA1) and Facilitates ApoA1 Secretion in Hepatocytes
por: Sampieri, Alicia, et al.
Publicado: (2023)

Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy
por: Gong, Miaomiao, et al.
Publicado: (2019)

ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice
por: Marino, J S, et al.
Publicado: (2012)

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
por: Lebherz, Corinna, et al.
Publicado: (2007)

The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells
por: Theodoros, Kelesidis, et al.
Publicado: (2021)

ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV
por: Daskou, M., et al.
Publicado: (2021)

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
por: Camacho, Jessica, et al.
Publicado: (2019)

The unsolved mystery of apoA-I recycling in adipocyte
por: Wang, Shuai, et al.
Publicado: (2016)

Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice
por: Venkat, Poornima, et al.
Publicado: (2023)

Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
por: Dalla-Riva, Jonathan, et al.
Publicado: (2013)

Intracranial Aneurysm Formation in Type-One Diabetes Rats
por: Yan, Tao, et al.
Publicado: (2013)

Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer
por: Chattopadhyay, Arnab, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5eajl7v5jps8svjs4p13pbs62i